Browse EX-10 agreements

Document

Exhibit 10.1

AMENDMENT NO. 2

TO THE 

CAREDX, INC.

2024 EQUITY INCENTIVE PLAN 

April 21, 2026

This Amendment No 2. (this “Amendment”) to the CareDx, Inc. 2024 Equity Incentive Plan (as previously amended by Amendment No. 1, the “Plan”) was adopted by the Board of Directors (the “Board”) of CareDx, Inc. (the “Company”), and following the Board’s approval of this Amendment as of the date first written above, will be effective as of the date on which this Amendment is approved by the stockholders of the Company (the “Amendment Effective Date”).

WHEREAS, the Company maintains the Plan, and pursuant to Section 7(b) of the Plan, the Board is authorized to amend the Plan;

WHEREAS, the Board desires to amend the Plan to increase the number of shares of the Company’s Common Stock reserved and available for issuance thereunder; and

…

AMENDMENT NO. 2 TO TERM LOAN CREDIT AGREEMENT AND CONSENT

AMENDMENT NO. 2 TO TERM LOAN CREDIT AGREEMENT AND CONSENT, dated as of June 15, 2026 (this “Amendment”), by and among ACCENDRA HEALTH, INC. (f/k/a OWENS & MINOR, INC.), a Virginia corporation (the “Parent Borrower”), BARISTA ACQUISITION I, LLC, a Virginia limited liability company (“Barista I”), BARISTA ACQUISITION II, LLC, a Virginia limited liability company (“Barista II”), BYRAM HEALTHCARE CENTERS, INC., a New Jersey corporation (“Byram”), APRIA, INC., a Delaware corporation (“Apria” and, together with the Parent Borrower, Barista I, Barista II and Byram, collectively, the “Borrowers”), the other Loan Parties party hereto, each Term A-1 Term Lender party hereto (collectively, the “Consenting Term A-1 Lenders”), each Term B-1 Term Lender party hereto (collectively, the “Consenting Term B-1 Lenders” and together with the Consenting Term A-1 Lenders, the “Consenting Lenders”), and JPMORGAN CHASE BANK, N.A., as the Administrative Agent and the Collateral Agent.

RECITALS:

…

AMENDMENT NO. 4 TO CREDIT AGREEMENT AND CONSENT

AMENDMENT NO. 4 TO CREDIT AGREEMENT AND CONSENT, dated as of June 15, 2026 (this “Amendment”), by and among ACCENDRA HEALTH, INC. (f/k/a OWENS & MINOR, INC.), a Virginia corporation (the “Parent Borrower”), BARISTA ACQUISITION I, LLC, a Virginia limited liability company (“Barista I”), BARISTA ACQUISITION II, LLC, a Virginia limited liability company (“Barista II”), BYRAM HEALTHCARE CENTERS, INC., a New Jersey corporation (“Byram”), APRIA, INC., a Delaware corporation (“Apria” and, together with the Parent Borrower, Barista I, Barista II and Byram, collectively, the “Borrowers”), the other Loan Parties party hereto, each Lender party hereto (collectively, the “Consenting Lenders”) and BANK OF AMERICA, N.A., as the Administrative Agent and the Collateral Agent, a L/C Issuer and the Swing Line Lender.

RECITALS:

…

Execution Version

VOTING AND SUPPORT AGREEMENT

This VOTING AND SUPPORT AGREEMENT (hereinafter referred to as this “Agreement”), is made and entered into as of June 14, 2026, by and among Fox Corporation, a Delaware corporation (“Parent”), and the undersigned stockholders (each, together with the holders of shares of Company Class A Common Stock listed on Schedule 2 hereto at such time as they become a party to this Agreement, a “Covered Stockholder”, and collectively, the “Covered Stockholders”) of Roku, Inc., a Delaware corporation (the “Company”).

RECITALS

…

Document

Exhibit 10.1

MASTER SERVICES AGREEMENT

This MASTER SERVICES AGREEMENT (the “Agreement”) is made by and between TETRA Bromine Project LLC, a Delaware limited liability company (“Company” or “Owner”) and the contractor identified on the signature page of this Agreement (“Contractor”) effective as of the last date shown on the signature page ("Effective Date"). Company and Contractor are individually referred to herein as a “Party” and collectively as the “Parties”.

…

Document

Exhibit 10.1

Execution Version

AMENDMENT NO. 14 TO THE CREDIT AGREEMENT

AMENDMENT NO. 14 to the Credit Agreement (as defined below), dated as of June 12, 2026 (this “Amendment”), among Cushman & Wakefield U.S. Borrower, LLC, a Delaware limited liability company (the “Borrower”), DTZ UK Guarantor Limited, a private limited company incorporated under the laws of England and Wales (“Holdings”), JPMorgan Chase Bank, N.A. (“JPMorgan Chase”), as administrative agent (in such capacity, the “Administrative Agent”), the Additional 2026-1 Term Lender (as defined below), the Converting 2025-2 Term Lenders (as defined below and, together with the Additional 2026-1 Term Lender, the “2026-1 Term Lenders”), and, solely for the purposes of Section 2.05 hereof, the Subsidiary Guarantors party hereto.

RECITALS

…

FIRST AMENDMENT TO CREDIT AGREEMENT

This FIRST AMENDMENT TO CREDIT AGREEMENT (this “First Amendment”) is dated as of June 12, 2026, and entered into by and between HAWK PARENT HOLDINGS LLC, a Delaware limited liability company (the “Borrower”), TRUIST BANK, as administrative agent (the “Administrative Agent”), and the Lenders party hereto, and is made to that certain Credit Agreement, dated as of June 1, 2026 (as amended, restated, amended and restated, supplemented or otherwise modified through the date hereof prior to the effectiveness of this First Amendment on the First Amendment Effective Date (as defined below), the “Existing Credit Agreement”; the Existing Credit Agreement as amended by this First Amendment, the “Amended Credit Agreement”), by and among REPAY HOLDINGS CORPORATION, a Delaware corporation, as Parent, the Borrower, the other Loan Parties party thereto from time to time, the Lenders and Issuing Banks party thereto from time to time and Truist Bank, as Administrative Agent and Swingline Lender. Capitalized terms used herein without definition shall have the same m

…

Document

Exhibit 10.1

Execution Version

AMENDMENT NO. 7 TO CREDIT AGREEMENT

    THIS AMENDMENT NO. 7 TO CREDIT AGREEMENT is entered into as of June 15, 2026 (this “Amendment”), by and among Talen Energy Supply, LLC, a Delaware limited liability company (the “Borrower”), the Subsidiary Guarantors party hereto, each Person identified on the signature pages hereof as a “2026-1 Additional Revolving Lender” (collectively, the “2026-1 Additional Revolving Lenders” and, each a “2026-1 Additional Revolving Lender”), each Person identified on the signature pages hereof as a “2026-1 Additional Stand-Alone L/C Issuer” (collectively, the “2026-1 Additional Stand-Alone L/C Issuers” and, each a “2026-1 Additional Stand-Alone L/C Issuer”), each other Stand-Alone L/C Issuer party hereto and Citibank, N.A., as Administrative Agent and Collateral Agent. Capitalized terms used but not defined herein shall have the meanings provided in the Amended Credit Agreement (as defined below).

RECITALS:

…

Intellectual Property License Agreement

 

This Intellectual Property License Agreement (“Agreement”), dated as of June 11, 2026 (the “Effective Date”), is by and between Project LightShift, Inc., a Florida corporation, with offices located at 4040 NE 2nd Avenue #7D, Miami, Florida 33137 (“Licensor” or “PLS”), and Quantum Cyber N.V., a public company organized under the laws of the Netherlands and listed on the Nasdaq Capital Market (NCM: QUCY), with offices located at 1501 Belvedere Road Suite 500, West Palm Beach, FL, 33406 (“Licensee” or “Quantum”) (collectively, the “Parties,” or each, individually, a “Party”).

 

WHEREAS, Licensor owns all right, title, and interest in and has the right to license to Licensee the Licensed Technology (as defined below);

 

WHEREAS, Licensee wishes to use the Licensed Technology in the Territory within the Licensed Field of Use (as defined below) and Licensor is willing to grant to Licensee a license to and under the Licensed Technology on the terms and conditions set out in this Agreement; and

…

VOTING AGREEMENT

 

This VOTING AGREEMENT (this “Agreement”) is entered into as of June 11, 2026, between Quantum Cyber N.V., a Dutch public company with limited liability (the “Company”) and Project LightShift, Inc., a Florida corporation (the “Stockholder”).

 

WHEREAS, as of the date hereof, the Stockholder is the sole record and beneficial owner of and has the sole power to vote (or to direct the voting of) such number of ordinary shares, €0.01 par value per share, held by the Stockholder on any applicable record date;

 

WHEREAS, the Stockholder is party to that that certain Intellectual Property License Agreement, dated as of June 11, 2026, by and between the Company and the Stockholder (the “IPL”), pursuant to which the Stockholder may receive additional ordinary shares of the Company (such shares, together with the shares held as of the date hereof by the Stockholder or otherwise acquired in the future by the Stockholder, collectively, the “Subject Shares”);

…

Milestone Pharmaceuticals Inc. 2019 Equity Incentive Plan, As Amended

 

MILESTONE PHARMACEUTICALS INC.

 

2019 EQUITY INCENTIVE PLAN

 

ADOPTED BY THE BOARD OF DIRECTORS: APRIL 10, 2019

APPROVED BY THE SHAREHOLDERS: APRIL 29, 2019

IPO DATE: MAY 8, 2019

AMENDED BY THE BOARD OF DIRECTORS: APRIL 19, 2022

APPROVED BY THE SHAREHOLDERS: JULY 5, 2022

AMENDED BY THE BOARD OF DIRECTORS: APRIL 30, 2025

APPROVED BY THE SHAREHOLDERS: JUNE 10, 2025

AMENDED BY THE BOARD OF DIRECTORS: MARCH 17, 2026

APPROVED BY THE SHAREHOLDERS: JUNE 10, 2026

 

1.              GENERAL.

…

TERMINATION AGREEMENT AND MUTUAL RELEASE

 

THIS TERMINATION AGREEMENT AND MUTUAL RELEASE (this “Agreement”) is made and entered into as of June 12, 2026 (the “Effective Date”), by and among Polomar Health Services, Inc., a Nevada corporation (“Polomar”), and Altanine, Inc., a Nevada corporation (“Altanine”), and, solely for purposes of Sections 4, 5 and 6 hereof, Pinata Holdings Inc., a Delaware corporation and wholly owned subsidiary of Altanine (“Pinata”). Polomar and Altanine are each referred to herein as a “Party” and collectively as the “Parties.”

 

RECITALS:

 

WHEREAS, the Parties, together with Polomar Merger Sub, Inc., a Nevada corporation and wholly owned subsidiary of Polomar (“Merger Sub”), entered into that certain Agreement and Plan of Merger dated as of July 23, 2025 (the “Original Merger Agreement”), providing for the merger of Merger Sub with and into Altanine, with Altanine surviving as a wholly owned subsidiary of Polomar (the “Contemplated Merger”);

…